Citation Impact
Citing Papers
Diet and Lifestyle Recommendations Revision 2006
2006 Standout
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
2002 Standout
Association Between Pulse Pressure and Mortality in Patients Undergoing Maintenance Hemodialysis
2002
Regulation of the Voltage Gated K<sup>+</sup> Channel K<sub>v1.3</sub> by Recombinant Human Klotho Protein
2014 Standout
First United Kingdom Heart and Renal Protection (UK-HARP-I) study: Biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease
2005 StandoutNobel
Vascular Calcification Mechanisms
2004 Standout
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction
2004 Standout
A Predictive Model for Progression of Chronic Kidney Disease to Kidney Failure
2011 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Survival advantages of obesity in dialysis patients
2005
THE CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR DISEASES IN CHRONIC KIDNEY DISEASE: Traditional Cardiac Risk Factors in Individuals with Chronic Kidney Disease
2003
The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report
2010 Standout
A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease
2007 Standout
Association of low blood pressure with increased mortality in patients with moderate to severe chronic kidney disease
2006
Cardiac calcification in adult hemodialysis patients
2002 Standout
Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing Dialysis
2000 Standout
Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis
2004 Standout
Survival after acute myocardial infarction in patients with end-stage renal disease: Results from the cooperative cardiovascular project
2000
Chronic kidney disease
2011 Standout
Klotho Deficiency Causes Vascular Calcification in Chronic Kidney Disease
2010 Standout
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
2006 Standout
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Multi-Ethnic Study of Atherosclerosis: Objectives and Design
2002 Standout
Serum Phosphate Levels and Mortality Risk among People with Chronic Kidney Disease
2004 Standout
Relative contributions of nutrition and inflammation to clinical outcome in dialysis patients
2001
The Metabolic Syndrome and Cardiovascular Risk
2010 Standout
Premature cardiovascular disease in chronic renal failure
2000
Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients
1999
Cardiorenal Syndrome
2008 Standout
Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
2005 Standout
Hypertension as a cardiovascular risk factor in end-stage renal failure
2002
Body fat mass and lean mass as predictors of survival in hemodialysis patients
2006
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients
2002 Standout
Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study
2006 Standout
Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness
2017 Standout
Human Vascular Smooth Muscle Cells Undergo Vesicle-Mediated Calcification in Response to Changes in Extracellular Calcium and Phosphate Concentrations
2004 Standout
Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)
2011
The Intersection of Risk and Benefit
2009
Importance of quantitative genetic variations in the etiology of hypertension
2000 StandoutNobel
Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients
2003
Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients
2000
The serum protein α2–Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification
2003 Standout
Traditional Cardiovascular Disease Risk Factors in Dialysis Patients Compared with the General Population
2002
Association of Elevated Serum PO4, Ca × PO4 Product, and Parathyroid Hormone with Cardiac Mortality Risk in Chronic Hemodialysis Patients
2001 Standout
Cardiovascular disease and chronic renal disease: A new paradigm
2000
The Hallmarks of Aging
2013 Standout
Prevalence of Chronic Kidney Disease in the United States
2007 Standout
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
2013 Standout
Diagnosis and Therapy of Coronary Artery Disease in Renal Failure, End-Stage Renal Disease, and Renal Transplant Populations
2003
Expert consensus document on arterial stiffness: methodological issues and clinical applications
2006 Standout
Chronic Kidney Disease
2016 Standout
Inflammation as a cause of malnutrition, atherosclerotic cardiovascular disease, and poor outcome in hemodialysis patients
2004
Causes and consequences of the reverse epidemiology of body mass index in dialysis patients
2005
Metabolic syndrome is associated with severe coronary artery disease and poor cardiac outcome in end-stage renal disease patients with acute coronary syndrome
2006
CARDIOVASCULAR AND SURVIVAL PARADOXES IN DIALYSIS PATIENTS: Reverse Epidemiology in Patients with Chronic Kidney Disease Who Are Not Yet on Dialysis
2007
Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness
2010 Standout
Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis
2005 Standout
Relative in Vitro Efficacy of the Phosphate Binders Lanthanum Carbonate and Sevelamer Hydrochloride
2007 StandoutNobel
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Managing phosphate retention: is a change necessary?
2000
Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline
2013 Standout
OSR1-Sensitive Renal Tubular Phosphate Reabsorption
2012
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2019 Standout
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure
2006 Standout
Bumetanide A Review of its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Use
1984
Phosphate Regulation of Vascular Smooth Muscle Cell Calcification
2000 Standout
K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients
2005
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003
Impact of Aortic Stiffness Attenuation on Survival of Patients in End-Stage Renal Failure
2001
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis
2010 Standout
National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification
2003 Standout
Works of Pradip Teredesai being referenced
“U” curve association of blood pressure and mortality in hemodialysis patients
1998
Uncoupling of proximal sodium bicarbonate from sodium phosphate transport by bumetanide
1978
Investigations into the mechanism of the phosphaturia induced by chlorothiazide.
1981